A clinical-stage, biopharmaceutical company is conducting a clinical study in conjunction with Dr. Dr. Harper of Wake Research Associates. This study will evaluate the effectiveness, safety, and tolerability of an investigational medication in the treatment of adults with essential tremor. This study will analyze the effects of this investigational medication, as compared with a placebo, on tremor severity.
Qualified Participants Must:
Be between 18 and 75 years of age
Diagnosed with ET for more than five years
Willing to discontinue current medication for ET for the duration of the study
Qualified Participants May Receive:
For more information or to participate in the study, contact Wake Research Associates.